Concepedia
3
Publications
153
Citations
H-Index
2008
Active since
Affiliations
Astellas Pharma (United Kingdom)(Current)
A. K. van Engen is an author at Astellas Pharma (United Kingdom).
Publications per year
2008–2014
Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection
Dilip Nathwani, Oliver A. Cornely, A. K. van Engen et al. · Journal of Antimicrobial Chemotherapy · 2014 · 85 citations · Full text
Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany
Oliver A. Cornely, M. Sidhu, Isaac Odeyemi et al. · Current Medical Research and Opinion · 2008 · 41 citations
Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic <i>Candida</i> infections in the UK
M. Sidhu, A. K. van Engen, J. Kleintjens et al. · Current Medical Research and Opinion · 2009 · 27 citations
Rows per page
1–3 of 3